loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Posenacaftor, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Posenacaftor

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: Posenacaftor [usan], Bn5ut8i0t9, Pti-801, 2095064-05-2, Posenacaftor (usan), Posenacaftor [inn]
    Molecular Formula
    C27H27NO5
    Molecular Weight
    445.5  g/mol
    InChI Key
    QUDOHCFOJCNKPK-QGZVFWFLSA-N
    FDA UNII
    BN5UT8I0T9
    PTI-801 represents a new class of drugs to treat pain. PTI-801 can minimize the opioid tolerance, dependence or addiction that is often associated with repeat use of oxycodone. It is a combination of oxycodone with ultralow-dose naltrexone, an opioid antagonist.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    8-methyl-2-(3-methyl-1-benzofuran-2-yl)-5-[(1R)-1-(oxan-4-yl)ethoxy]quinoline-4-carboxylic acid
    2.1.2 InChI
    InChI=1S/C27H27NO5/c1-15-8-9-23(32-17(3)18-10-12-31-13-11-18)24-20(27(29)30)14-21(28-25(15)24)26-16(2)19-6-4-5-7-22(19)33-26/h4-9,14,17-18H,10-13H2,1-3H3,(H,29,30)/t17-/m1/s1
    2.1.3 InChI Key
    QUDOHCFOJCNKPK-QGZVFWFLSA-N
    2.1.4 Canonical SMILES
    CC1=C2C(=C(C=C1)OC(C)C3CCOCC3)C(=CC(=N2)C4=C(C5=CC=CC=C5O4)C)C(=O)O
    2.1.5 Isomeric SMILES
    CC1=C2C(=C(C=C1)O[C@H](C)C3CCOCC3)C(=CC(=N2)C4=C(C5=CC=CC=C5O4)C)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    BN5UT8I0T9
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Posenacaftor [usan]

    2. Bn5ut8i0t9

    3. Pti-801

    4. 2095064-05-2

    5. Posenacaftor (usan)

    6. Posenacaftor [inn]

    7. Unii-bn5ut8i0t9

    8. Posenacaftor [who-dd]

    9. Chembl4594274

    10. Schembl18736773

    11. Glxc-25544

    12. Who 11276

    13. Hy-109187

    14. Cs-0116460

    15. D11683

    16. (r)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2h-pyran-4- Yl)ethoxy)quinoline-4-carboxylate

    17. 4-quinolinecarboxylic Acid, 8-methyl-2-(3-methyl-2-benzofuranyl)-5-((1r)-1-(tetrahydro-2h-pyran-4-yl)ethoxy)

    18. 4-quinolinecarboxylic Acid, 8-methyl-2-(3-methyl-2-benzofuranyl)-5-((1r)-1-(tetrahydro-2h-pyran-4-yl)ethoxy)-

    19. 8-methyl-2-(3-methyl-1-benzofuran-2-yl)-5-[(1r)-1-(oxan-4-yl)ethoxy]quinoline-4-carboxylic Acid

    20. 8-methyl-2-(3-methylbenzofuran-2-yl)-5-((1r)-1-(oxan-4-yl)ethoxy)quinoline-4-carboxylic Acid

    2.4 Create Date
    2017-08-04
    3 Chemical and Physical Properties
    Molecular Weight 445.5 g/mol
    Molecular Formula C27H27NO5
    XLogP35.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count5
    Exact Mass445.18892296 g/mol
    Monoisotopic Mass445.18892296 g/mol
    Topological Polar Surface Area81.8 Ų
    Heavy Atom Count33
    Formal Charge0
    Complexity681
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in addictions, osteoarthritis, and pain (acute or chronic).

    5 Pharmacology and Biochemistry
    5.1 Mechanism of Action

    PTI-801 is a novel form of oxycodone that minimizes the abuse and drug dependence that is often associated with oxycodone and other narcotic painkillers. The goal of developing PTI-801 is to ensure the safety of patients who have a legitimate medical need to treat severe chronic pain with a narcotic painkiller, and to protect the public from the consequences of abuse.

    Post Enquiry
    POST ENQUIRY